SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-027125
Filing Date
2021-02-03
Accepted
2021-02-03 14:52:58
Documents
3
Group Members
CANAAN PARTNERS X LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d101985dsc13ga.htm SC 13G/A 64198
2 EX-24 d101985dex24.htm EX-24 13281
3 EX-99.1 d101985dex991.htm EX-99.1 3812
  Complete submission text file 0001193125-21-027125.txt   82816
Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Filed by) CIK: 0001619859 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91004 | Film No.: 21585836
SIC: 2834 Pharmaceutical Preparations